Trevena Inc. (TRVN)

$0.01

up-down-arrow $0.01 (1,010.00%)

As on 16-Jun-2026 14:16EDT

Market cap

info icon

$0 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.4

Div. Yield

info icon

0 %

Trevena (TRVN) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.01 High: 0.01

52 Week Range

Low: 0.00 High: 1.14

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -10.1 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    0.2

  • Debt to EquityDebt to Equity information

    -1.4

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-35.8

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    863,788

10 Years Aggregate

CFO

$-447.81 Mln

EBITDA

$-490.56 Mln

Net Profit

$-508.41 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Trevena (TRVN)
-7.5 0.9 0.9 -98.9 -92.5 -90.3 -72.3
BSE Sensex*
-8.6 2.9 1.8 -5.1 6.9 8.1 11.3
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 16-Jun-2026  |  *As on 18-Jun-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Trevena (TRVN)
-99.2 -91.6 -49.5 -90.2 -72.8 154.5 95.6
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Trevena (TRVN)
0.0 0.0 0.6 -34.0 -3,005.9 -- -- 0.4
282.7 37,764.0 4,286.9 577.2 20.3 88.2 70.9 35.1
231.2 14,299.5 867.5 506.6 -0.6 -- 25 25.4
52.4 13,354.5 2,375.5 833.4 41.5 40.7 17.6 6.9
129.1 17,452.8 1,080.2 -433.2 -39.8 -- -- 55.7
170.7 29,936.9 16,632.0 1,385.0 14.1 22.3 22.3 4.9
457.1 13,347.1 2,678.3 460.4 21.3 103.2 29.4 22.3
607.9 64,176.2 14,919.6 4,423.4 34.9 14.2 14.9 2.0
551.5 23,174.2 3,169.8 1,287.4 51.3 20.6 20.2 3.9
459.0 112,924.4 12,255.1 4,338.3 32.0 23.7 26.4 5.8

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Trevena (TRVN)

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G...  protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. 

  • President, CEO & Chairman

    Ms. Carrie L. Bourdow

  • President, CEO & Chairman

    Ms. Carrie L. Bourdow

  • Headquarters

    Chesterbrook, PA

  • Website

    https://www.trevena.com

Edit peer-selector-edit
loading...
loading...

FAQs for Trevena (TRVN)

The share price of Trevena Inc (TRVN) is $0.01 (NASDAQ) as of 16-Jun-2026 14:16 EDT. Trevena Inc (TRVN) has given a return of -92.47% in the last 3 years.

Since, TTM earnings of Trevena Inc (TRVN) is negative, P/E ratio is not available.
The P/B ratio of Trevena Inc (TRVN) is 0.36 times as on 12-Jun-2026, a 91 discount to its peers’ median range of 4.14 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2023
-0.01
-0.07
2022
-0.38
1.30
2021
-0.08
0.06
2020
-0.46
0.13
2019
-0.13
0.11

The 52-week high and low of Trevena Inc (TRVN) are Rs 1.14 and Rs 0.00 as of 18-Jun-2026.

Trevena Inc (TRVN) has a market capitalisation of $ 0 Mln as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Trevena Inc (TRVN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.